More than 5 million Americans struggle with opioid use disorder, a physical addiction entwined with America’s health crisis, homeless crisis and mental health crisis. The most successful, evidence-based road to recovery is medication coupled with counseling, like that offered at Comprehensive Treatment Centers.
Still, 75 percent of people with opioid use disorder don’t have access to these FDA-approved medications, including buprenorphine, methadone and naltrexone. Despite federal regulations that should improve access to these medications, lack of oversights and stigma at the point of care often prevent successful treatment.
Why? Studies across the United States show an upsetting trend: treatment centers, recovery residencies, and Narcotics Anonymous are prohibiting and stigmatizing medications for opioid use disorder (MOUDs).
